Ciliated/tubal-type in-situ and invasive endocervical adenocarcinoma: Report of three cases with limited follow-up and review of the literature

• Published in: Gynecologic oncology reports Vol. 42; p. 101025
• Main Authors: Marketkar, Shivali, Ou, Joyce, James Sung, C., Ruhul Quddus, M.
• Format: Journal Article
• Language: English
• Published: Elsevier 01.08.2022
• Subjects: Case Series; Cilia/tubal; Endocervical adenocarcinoma; Endocervical AIS; hrHPV; P16
• ISSN: 2352-5789; 2352-5789
• DOI: 10.1016/j.gore.2022.101025

• Ciliated type adenocarcinoma in situ (AIS), rare type of AIS insufficiently studied. • Ciliated type endocervical carcinoma rare, not described in the WHO. • Subtype of HPV associated endocervical AIS/carcinoma. • Found in young females with good prognosis on limited follow up. In situ (AIS) and invasive endocervical adenocarcinoma have two broad categories, HPV-associated (HPV) and HPV-independent groups. (1) These entities show various types of cell morphology. Tubal and tubo-endometrioid type metaplasia of the cervix is a benign finding (Suh and Silverberg, 1990). Tubal metaplasia is also encountered in benign and malignant endometrial lesions. During cervical biopsy interpretations, differentiating the site of origin of the tissue is often tricky. We intend to document three cases of the sparsely reported hrHPV-associated ciliated/tubal-type endocervical AIS and invasive adenocarcinoma and bring it to the attention of readers how to avoid any misinterpretation during routine sign-out. Only three of fifty-three cases of hrHPV-associated AIS and invasive adenocarcinoma were of ciliated/tubal type in our department over a 5-year time. The presence of tubal-type epithelium should not automatically trigger the assumption of endometrial origin of the lesion. These cases are red herrings as tubal/ciliated type dysplasia, and carcinoma is rare and have potential to escape accurate diagnosis.